Is Bayer (BAYRY) Outperforming Other Medical Stocks This Year?
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Bayer Aktiengesellschaft (BAYRY) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question.
Bayer Aktiengesellschaft is a member of our Medical group, which includes 997 different companies and currently sits at #4 in the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.
The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. Bayer Aktiengesellschaft is currently sporting a Zacks Rank of #2 (Buy).
Over the past 90 days, the Zacks Consensus Estimate for BAYRY's full-year earnings has moved 9.4% higher. This means that analyst sentiment is stronger and the stock's earnings outlook is improving.
Based on the latest available data, BAYRY has gained about 45.3% so far this year. Meanwhile, stocks in the Medical group have lost about 5.8% on average. This means that Bayer Aktiengesellschaft is performing better than its sector in terms of year-to-date returns.
One other Medical stock that has outperformed the sector so far this year is BioCryst Pharmaceuticals (BCRX). The stock is up 43.5% year-to-date.
For BioCryst Pharmaceuticals, the consensus EPS estimate for the current year has increased 359.5% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
Looking more specifically, Bayer Aktiengesellschaft belongs to the Large Cap Pharmaceuticals industry, a group that includes 11 individual stocks and currently sits at #41 in the Zacks Industry Rank. Stocks in this group have lost about 4.3% so far this year, so BAYRY is performing better this group in terms of year-to-date returns.
On the other hand, BioCryst Pharmaceuticals belongs to the Medical - Drugs industry. This 161-stock industry is currently ranked #56. The industry has moved -0.9% year to date.
Investors interested in the Medical sector may want to keep a close eye on Bayer Aktiengesellschaft and BioCryst Pharmaceuticals as they attempt to continue their solid performance.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Bayer Aktiengesellschaft (BAYRY) : Free Stock Analysis Report
BioCryst Pharmaceuticals, Inc. (BCRX) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 days ago
- Yahoo
Costamare (CMRE) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Costamare (CMRE) ended the recent trading session at $9.19, demonstrating a -3.97% change from the preceding day's closing price. The stock's performance was behind the S&P 500's daily loss of 0.22%. At the same time, the Dow added 0.08%, and the tech-heavy Nasdaq lost 0.51%. Prior to today's trading, shares of the shipping company had gained 15.02% outpaced the Transportation sector's loss of 2.83% and the S&P 500's gain of 0.45%. The investment community will be paying close attention to the earnings performance of Costamare in its upcoming release. The company is expected to report EPS of $0.67, down 12.99% from the prior-year quarter. Regarding the entire year, the Zacks Consensus Estimates forecast earnings of $2.82 per share and revenue of $0 million, indicating changes of +2.17% and 0%, respectively, compared to the previous year. Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Costamare. Such recent modifications usually signify the changing landscape of near-term business trends. As such, positive estimate revisions reflect analyst optimism about the business and profitability. Our research shows that these estimate changes are directly correlated with near-term stock prices. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model. The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has remained unchanged. Costamare is holding a Zacks Rank of #3 (Hold) right now. Looking at its valuation, Costamare is holding a Forward P/E ratio of 3.39. This valuation marks a discount compared to its industry average Forward P/E of 9.62. The Transportation - Shipping industry is part of the Transportation sector. This industry, currently bearing a Zacks Industry Rank of 192, finds itself in the bottom 22% echelons of all 250+ industries. The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Keep in mind to rely on to watch all these stock-impacting metrics, and more, in the succeeding trading sessions. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Costamare Inc. (CMRE) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio
Yahoo
2 days ago
- Yahoo
Ardmore Shipping (ASC) Declines More Than Market: Some Information for Investors
Ardmore Shipping (ASC) closed at $10.13 in the latest trading session, marking a -3.89% move from the prior day. This move lagged the S&P 500's daily loss of 0.22%. Elsewhere, the Dow gained 0.08%, while the tech-heavy Nasdaq lost 0.51%. The stock of shipping company has risen by 9.91% in the past month, leading the Transportation sector's loss of 2.83% and the S&P 500's gain of 0.45%. Analysts and investors alike will be keeping a close eye on the performance of Ardmore Shipping in its upcoming earnings disclosure. On that day, Ardmore Shipping is projected to report earnings of $0.24 per share, which would represent a year-over-year decline of 78.76%. Meanwhile, our latest consensus estimate is calling for revenue of $44.45 million, down 48.68% from the prior-year quarter. For the full year, the Zacks Consensus Estimates are projecting earnings of $1.17 per share and revenue of $180.69 million, which would represent changes of -58.8% and -33.85%, respectively, from the prior year. It's also important for investors to be aware of any recent modifications to analyst estimates for Ardmore Shipping. Recent revisions tend to reflect the latest near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the business outlook. Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model. The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed an unchanged state. Right now, Ardmore Shipping possesses a Zacks Rank of #3 (Hold). In the context of valuation, Ardmore Shipping is at present trading with a Forward P/E ratio of 9.01. This denotes a discount relative to the industry average Forward P/E of 9.62. The Transportation - Shipping industry is part of the Transportation sector. This industry currently has a Zacks Industry Rank of 192, which puts it in the bottom 22% of all 250+ industries. The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Be sure to use to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Ardmore Shipping Corporation (ASC) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 days ago
- Yahoo
Amerigo Resources (ARREF) Declines More Than Market: Some Information for Investors
Amerigo Resources (ARREF) closed at $1.34 in the latest trading session, marking a -2.9% move from the prior day. This change lagged the S&P 500's daily loss of 0.22%. Elsewhere, the Dow saw an upswing of 0.08%, while the tech-heavy Nasdaq depreciated by 0.51%. The copper and molybdenum mining company's stock has climbed by 8.41% in the past month, exceeding the Basic Materials sector's gain of 2.25% and the S&P 500's gain of 0.45%. The upcoming earnings release of Amerigo Resources will be of great interest to investors. The company is expected to report EPS of $0.05, down 16.67% from the prior-year quarter. For the annual period, the Zacks Consensus Estimates anticipate earnings of $0.21 per share and a revenue of $0 million, signifying shifts of +75% and 0%, respectively, from the last year. Investors should also note any recent changes to analyst estimates for Amerigo Resources. Such recent modifications usually signify the changing landscape of near-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential. Our research shows that these estimate changes are directly correlated with near-term stock prices. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system. The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. The Zacks Consensus EPS estimate remained stagnant within the past month. Amerigo Resources currently has a Zacks Rank of #3 (Hold). From a valuation perspective, Amerigo Resources is currently exchanging hands at a Forward P/E ratio of 6.57. This valuation marks a discount compared to its industry average Forward P/E of 23.38. We can also see that ARREF currently has a PEG ratio of 0.33. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. As of the close of trade yesterday, the Mining - Non Ferrous industry held an average PEG ratio of 0.89. The Mining - Non Ferrous industry is part of the Basic Materials sector. With its current Zacks Industry Rank of 97, this industry ranks in the top 40% of all industries, numbering over 250. The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Don't forget to use to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Amerigo Resources Ltd. (ARREF) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio
